Jing-jie Wang

Dr. Jing-jie Wang

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
JWJing-jie Wang
Jing-jie Wang
XLXin-Xin Liu
Xin-Xin Liu
CZChen-Chen Zhu
Chen-Chen Zhu
TWTian-Zuo Wang
Tian-Zuo Wang
SWSi-Yu Wang
Si-Yu Wang
KNKai-hui Nan
Kai-hui Nan

20 January 2022 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
TWTian-Zuo Wang
Tian-Zuo Wang
BGBin Guan
Bin Guan
XLXin-Xin Liu
Xin-Xin Liu
LKLin-Nan Ke
Lin-Nan Ke
JWJing-jie Wang
Jing-jie Wang
KNKai-hui Nan
Kai-hui Nan

15 June 2020 in Macromolecular Bioscience
Verified
Journal Article
Closed access
PDF file
CZCaijie Zhang
Caijie Zhang
YZYingying Zheng
Yingying Zheng
MLMin Li
Min Li
ZZZhongfang Zhang
Zhongfang Zhang
LCLianqing Chang
Lianqing Chang
ZZZhimin Zhou
Zhimin Zhou

1 October 2021 in International Journal of Electrical Power & Energy Systems
Verified
Journal Article
Closed access
JWJing-jie Wang
Jing-jie Wang
HWHongbin Wu
Hongbin Wu
SYShihai Yang
Shihai Yang
RBRui Bi
Rui Bi
JLJunhua Lu
Junhua Lu

31 December 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
TWTian-Zuo Wang
Tian-Zuo Wang
XLXinxin Liu
Xinxin Liu
SWSi-Yu Wang
Si-Yu Wang
YLYan Liu
Yan Liu
XPXin-Yang Pan
Xin-Yang Pan
KNKai-hui Nan
Kai-hui Nan
Dry eye disease (DED) is a widespread and frequently reported multifactorial ocular disease that not only causes ocular discomfort but also damages the cornea and conjunctiva. At present, topical administration is the most common treatment modality for DED. Due to the existence of multiple biological barriers, instilled drugs generally exhibit short action times and poor penetration on the ocular surface. To resolve these issues, several advanced drug delivery systems have been proposed. This review discusses new dosage forms of drugs for the treatment of DED in terms of their characteristics and advantages. Innovative formulations that are currently available in the market and under clinical investigation are elaborated. Meanwhile, their deficiencies are discussed. It is envisioned that the flourishing of advanced drug delivery systems will lead to improved management of DED in the near future.

25 December 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
XPXin-Yang Pan
Xin-Yang Pan
ZWZi-Han Wang
Zi-Han Wang
XWXiao-Qing Wu
Xiao-Qing Wu
CGChang-Rong Guo
Chang-Rong Guo
LYLin-Xing Yang
Lin-Xing Yang
LLLingli Li
Lingli Li